| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor | 6.96e-04 | 34 | 23 | 2 | GO:0016628 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on the CH-CH group of donors | 2.30e-03 | 62 | 23 | 2 | GO:0016627 | |
| GeneOntologyMolecularFunction | cysteine-type endopeptidase activity | 4.37e-03 | 86 | 23 | 2 | GO:0004197 | |
| GeneOntologyMolecularFunction | flavin adenine dinucleotide binding | 5.20e-03 | 94 | 23 | 2 | GO:0050660 | |
| GeneOntologyMolecularFunction | phosphoric diester hydrolase activity | 5.53e-03 | 97 | 23 | 2 | GO:0008081 | |
| GeneOntologyBiologicalProcess | non-proteinogenic amino acid metabolic process | 1.05e-04 | 87 | 22 | 3 | GO:0170041 | |
| GeneOntologyBiologicalProcess | homocysteine metabolic process | 1.13e-04 | 15 | 22 | 2 | GO:0050667 | |
| GeneOntologyBiologicalProcess | response to xenobiotic stimulus | 1.93e-04 | 525 | 22 | 5 | GO:0009410 | |
| GeneOntologyBiologicalProcess | pyrimidine nucleobase metabolic process | 2.48e-04 | 22 | 22 | 2 | GO:0006206 | |
| GeneOntologyBiologicalProcess | regulation of DNA metabolic process | 2.69e-04 | 564 | 22 | 5 | GO:0051052 | |
| GeneOntologyBiologicalProcess | amino acid metabolic process | 3.83e-04 | 332 | 22 | 4 | GO:0006520 | |
| GeneOntologyBiologicalProcess | regulation of DNA biosynthetic process | 4.11e-04 | 138 | 22 | 3 | GO:2000278 | |
| GeneOntologyBiologicalProcess | pyrimidine ribonucleotide metabolic process | 5.97e-04 | 34 | 22 | 2 | GO:0009218 | |
| GeneOntologyBiologicalProcess | DNA metabolic process | 7.38e-04 | 1081 | 22 | 6 | GO:0006259 | |
| GeneOntologyBiologicalProcess | sulfur amino acid metabolic process | 8.27e-04 | 40 | 22 | 2 | GO:0000096 | |
| GeneOntologyBiologicalProcess | interstrand cross-link repair | 9.11e-04 | 42 | 22 | 2 | GO:0036297 | |
| GeneOntologyBiologicalProcess | nucleobase metabolic process | 1.05e-03 | 45 | 22 | 2 | GO:0009112 | |
| Domain | VIT | 5.93e-05 | 10 | 22 | 2 | PS51468 | |
| Domain | VIT | 5.93e-05 | 10 | 22 | 2 | IPR013694 | |
| Domain | - | 3.40e-03 | 74 | 22 | 2 | 3.40.50.410 | |
| Domain | VWFA | 4.15e-03 | 82 | 22 | 2 | PS50234 | |
| Domain | VWA | 4.36e-03 | 84 | 22 | 2 | SM00327 | |
| Domain | VWF_A | 6.00e-03 | 99 | 22 | 2 | IPR002035 | |
| Pathway | REACTOME_FANCONI_ANEMIA_PATHWAY | 2.16e-05 | 39 | 20 | 3 | MM15318 | |
| Pathway | REACTOME_FANCONI_ANEMIA_PATHWAY | 2.16e-05 | 39 | 20 | 3 | M14990 | |
| Pathway | PID_FANCONI_PATHWAY | 3.81e-05 | 47 | 20 | 3 | M1 | |
| Pathway | WP_DNA_REPAIR_PATHWAYS_FULL_NETWORK | 6.17e-04 | 120 | 20 | 3 | M40049 | |
| Pubmed | Mechanism of Ubiquitination and Deubiquitination in the Fanconi Anemia Pathway. | 3.25e-05 | 13 | 23 | 2 | 27986371 | |
| Pubmed | 4.37e-05 | 15 | 23 | 2 | 19536649 | ||
| Pubmed | 1.35e-04 | 26 | 23 | 2 | 23435420 | ||
| Pubmed | 1.64e-04 | 814 | 23 | 5 | 23251661 | ||
| Pubmed | CYLD Regulates Centriolar Satellites Proteostasis by Counteracting the E3 Ligase MIB1. | 2.31e-04 | 182 | 23 | 3 | 31067453 | |
| Pubmed | 2.94e-04 | 497 | 23 | 4 | 23414517 | ||
| Pubmed | FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia. | 2.94e-04 | 497 | 23 | 4 | 36774506 | |
| Pubmed | 5.29e-04 | 1049 | 23 | 5 | 27880917 | ||
| Pubmed | 6.53e-04 | 57 | 23 | 2 | 21555454 | ||
| Cytoband | Ensembl 112 genes in cytogenetic band chr15q25 | 2.91e-03 | 160 | 23 | 2 | chr15q25 | |
| ToppCell | 356C-Fibroblasts-Fibroblast-E|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 4.58e-05 | 136 | 23 | 3 | edfd453c9a650d69d05a5a3ab15f7df56349fa86 | |
| ToppCell | 356C-Fibroblasts-Fibroblast-E-|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 4.58e-05 | 136 | 23 | 3 | 03e4e2353c23ceffde35b2d0aadd15299e3db09f | |
| ToppCell | saliva-Severe-critical_progression_d12-22_with-steroid-Myeloid-Macrophage-macrophage,_alveolar-Macro_c2-CCL3L1|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 7.84e-05 | 163 | 23 | 3 | 130c84bca3f72ab7d1a4fee2990c3d01600318ed | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L1-6_VIP_RGS16|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.19e-05 | 172 | 23 | 3 | 8b396d1e9173da104d467e42286379fe07cee257 | |
| ToppCell | droplet-Kidney-nan-18m|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.12e-04 | 184 | 23 | 3 | e02859bbac36dbbd55d7ae8cb5e46b764d7c6381 | |
| ToppCell | 5'-Adult-LymphNode-Epithelial-goblet-BEST2+_Goblet_cell|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.25e-04 | 191 | 23 | 3 | e5c41c3054ead03597c136eaccaf9822e6bb9d1a | |
| ToppCell | 5'-Adult-LymphNode-Epithelial-goblet|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.25e-04 | 191 | 23 | 3 | 7e24175c7fabe5ea0b22b73173da4c3a666e5eb8 | |
| ToppCell | COPD-Myeloid|COPD / Disease state, Lineage and Cell class | 1.29e-04 | 193 | 23 | 3 | f58552e286aa27e592497ad78776f58f8ee09841 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_myocytic-mes_proliferating_SM_(20)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 1.31e-04 | 194 | 23 | 3 | 590a9d4f054e6a3685daf752c9354650fcc7d18a | |
| ToppCell | Control-Myeloid|Control / Disease state, Lineage and Cell class | 1.33e-04 | 195 | 23 | 3 | 46ce2e403ca5d757e5ba17349b6c7ce5cde1f195 | |
| ToppCell | PBMC-Control-Myeloid-Classical_Monocyte-Classical_Monocyte-cMono_2|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.33e-04 | 195 | 23 | 3 | 0110b976f98561ecd2e20ff6e7e3960a401bb7c2 | |
| ToppCell | IPF-Myeloid|IPF / Disease state, Lineage and Cell class | 1.33e-04 | 195 | 23 | 3 | fdeb958aeaa00f3fc25c4e59efbbc6f4a572c9ce | |
| ToppCell | PBMC-Control-Myeloid-Classical_Monocyte-Classical_Monocyte-cMono_2|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.33e-04 | 195 | 23 | 3 | 050fc59b328391d6e3ce23051764a842dcbb3144 | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_cycling-mes_proliferating1_(3)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 1.33e-04 | 195 | 23 | 3 | 56d8734d020b3da08a5aa9e67999706a9e023a99 | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_cycling-mes_proliferating1_(3)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.33e-04 | 195 | 23 | 3 | b65463a804fed2d9a3be9e528ca8b9c98469bc86 | |
| ToppCell | 10x_3'_v3-blood_(10x_3'_v3)-myeloid-myeloid_monocytic-classical_monocyte|blood_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.35e-04 | 196 | 23 | 3 | 28e9e191361966df3a9bd48450090577aa72a999 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Myeloid-Monocytic-Classical_Monocyte|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.37e-04 | 197 | 23 | 3 | 2afc23f7394d9b40bdf06527c5e6b553e1b02dca | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Myeloid-Monocytic-Classical_Monocyte-Mono_c3-CD14-VCAN|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.37e-04 | 197 | 23 | 3 | 15bcfe6105c0b508811fb9bba0bc4312fea04f4c | |
| ToppCell | 3'_v3-lymph-node_spleen-Myeloid_Monocytic-Classical_monocytes|lymph-node_spleen / Manually curated celltypes from each tissue | 1.39e-04 | 198 | 23 | 3 | 187a04d498f0b355cb11c81172721698818082d6 | |
| ToppCell | COVID-19_Mild-Myeloid-Classical_Monocyte|COVID-19_Mild / Disease group, lineage and cell class | 1.39e-04 | 198 | 23 | 3 | e78d027a095473af555762a4d542a73f5bb2e166 | |
| ToppCell | 10x_3'_v3-spleen_(10x_3'_v3)-myeloid-myeloid_monocytic-classical_monocyte|spleen_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.39e-04 | 198 | 23 | 3 | 74591eba5dbb2d77d416309326a26be969e4ad42 | |
| ToppCell | 10x_3'_v3-spleen_(10x_3'_v3)-myeloid-myeloid_monocytic|spleen_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.39e-04 | 198 | 23 | 3 | 3e1e79bb7b13540a06956b59c6a62984efea19ee | |
| ToppCell | PBMC-Mild-cDC_0|Mild / Compartment, Disease Groups and Clusters | 1.39e-04 | 198 | 23 | 3 | fb873b7636bb1c7b119dd5b23d7a20f518e6c6da | |
| ToppCell | 3'_v3-lymph-node_spleen-Myeloid_Monocytic|lymph-node_spleen / Manually curated celltypes from each tissue | 1.39e-04 | 198 | 23 | 3 | 065c8a9655d19f93dfdb453c78bbfe7d857caf3e | |
| ToppCell | PBMC-Mild-Myeloid-Classical_Monocyte-Classical_Monocyte-cMono_2|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.41e-04 | 199 | 23 | 3 | 96dfbcf5261286f17d9718b04ebb7b288d229b52 | |
| ToppCell | BAL-Severe-Myeloid-MoAM-MoAM3-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.41e-04 | 199 | 23 | 3 | b2dc3d0af6ecd3ab01779aaa1f061cb0f941cae8 | |
| ToppCell | Healthy_donor-Classical_Monocyte|World / disease group, cell group and cell class (v2) | 1.41e-04 | 199 | 23 | 3 | 45e9099a13becb1e235435ceaaffb92b82ce34ee | |
| ToppCell | Severe_COVID-19-Myeloid-MoAM3|Severe_COVID-19 / Disease group,lineage and cell class (2021.01.30) | 1.41e-04 | 199 | 23 | 3 | 30523cf08815ca214877e33a2c52197ff8318557 | |
| ToppCell | PBMC-Mild-Myeloid-Classical_Monocyte-Classical_Monocyte-cMono_2|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.41e-04 | 199 | 23 | 3 | 87d513a521dd0359f4f79b01e9e97eacb0a3c6e2 | |
| ToppCell | BAL-Severe-cDC_0|Severe / Compartment, Disease Groups and Clusters | 1.41e-04 | 199 | 23 | 3 | d39be8b173156bf87baddd3caed4b35597c53ea1 | |
| ToppCell | PBMC-Control-cDC_0|Control / Compartment, Disease Groups and Clusters | 1.41e-04 | 199 | 23 | 3 | ebf03979ef56e978d72db475bb635b43b9cbe402 | |
| ToppCell | 10x_3'_v3-blood_(10x_3'_v3)-myeloid|blood_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.41e-04 | 199 | 23 | 3 | 126a0ebd40e55c0dfb5e7c7dd8fdd733da6aa323 | |
| ToppCell | BAL-Severe-Myeloid-MoAM-MoAM3|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.41e-04 | 199 | 23 | 3 | 0892957a49304ce4b6daa3657d76d8365ce0dd19 | |
| ToppCell | BAL-Severe-Myeloid-MoAM-MoAM3|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.41e-04 | 199 | 23 | 3 | 105709b97c55826a852aed27658e3b4af1738c8a | |
| ToppCell | BAL-Severe-Myeloid-MoAM-MoAM3-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.41e-04 | 199 | 23 | 3 | 961ad44199871be8e09d31904d383edc865ba262 | |
| ToppCell | healthy_donor-Myeloid-Monocytic-CD14+_Monocyte|healthy_donor / Disease condition, Lineage, Cell class and subclass | 1.44e-04 | 200 | 23 | 3 | e4f4ac674f3e085f52c6affeb6aeadaec7fffa73 | |
| ToppCell | COVID_vent-Myeloid-Monocytic-CD14+_Monocyte|COVID_vent / Disease condition, Lineage, Cell class and subclass | 1.44e-04 | 200 | 23 | 3 | e57452b73abb21cb3f645d45523ab93f6bef0243 | |
| ToppCell | control-HLA-DR-_S100A+_Monocyte|control / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.44e-04 | 200 | 23 | 3 | 9e3e13a68bc1110fa000ec2d80f4c654ddbce17e | |
| ToppCell | mild-HLA-DR+_CD83+_Monocyte|mild / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.44e-04 | 200 | 23 | 3 | 8a480f487b52938d00b53bf4b18f067353d34419 | |
| ToppCell | COVID-19-COVID-19_Mild-Myeloid-CD14+_Monocyte|COVID-19_Mild / Disease, condition lineage and cell class | 1.44e-04 | 200 | 23 | 3 | f76d3647f8ab5f7be018b0697c911597198e03f5 | |
| ToppCell | Hippocampus-Neuronal-Inhibitory-iN2(Gad1Gad2)-Gfra1-Inhibitory_Neuron.Gad1Gad2_Pvalb.Gfra1_(Interneuron,_Basket_1)-|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 4.06e-04 | 58 | 23 | 2 | f058992ac3c6c3bd56ff0d1e0c9de1d61e15b387 | |
| ToppCell | Hippocampus-Neuronal-Inhibitory-iN2(Gad1Gad2)-Gfra1-Inhibitory_Neuron.Gad1Gad2_Pvalb.Gfra1_(Interneuron,_Basket_1)|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 4.06e-04 | 58 | 23 | 2 | f9971c7e50844116d831be1c47fce1d213ac7228 | |
| ToppCell | Hippocampus-Neuronal-Inhibitory-iN2(Gad1Gad2)-Gfra1|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 4.06e-04 | 58 | 23 | 2 | a58f4ee94896c1f790335245163179f52705fae7 | |
| Computational | Neighborhood of AIP | 3.13e-05 | 40 | 17 | 3 | GCM_AIP | |
| Disease | Fanconi anemia (implicated_via_orthology) | 1.62e-05 | 8 | 23 | 2 | DOID:13636 (implicated_via_orthology) | |
| Disease | gamma-glutamylglutamate measurement | 5.26e-05 | 14 | 23 | 2 | EFO_0021137 | |
| Disease | Colonic Neoplasms | 2.20e-04 | 152 | 23 | 3 | C0009375 | |
| Disease | Malignant tumor of colon | 2.51e-04 | 159 | 23 | 3 | C0007102 | |
| Disease | Malignant Head and Neck Neoplasm | 5.39e-04 | 44 | 23 | 2 | C0278996 | |
| Disease | Peripheral Nervous System Diseases | 8.11e-04 | 54 | 23 | 2 | C4721453 | |
| Disease | Alzheimer's disease (implicated_via_orthology) | 9.04e-04 | 57 | 23 | 2 | DOID:10652 (implicated_via_orthology) | |
| Disease | social interaction measurement | 2.43e-03 | 94 | 23 | 2 | EFO_0009592 | |
| Disease | corneal topography | 3.25e-03 | 109 | 23 | 2 | EFO_0004345 | |
| Disease | docosahexaenoic acid measurement | 4.38e-03 | 127 | 23 | 2 | EFO_0007761 | |
| Disease | hypertension (implicated_via_orthology) | 4.45e-03 | 128 | 23 | 2 | DOID:10763 (implicated_via_orthology) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| PKHFRKDVDVVCVDM | 116 | Q15361 | |
| EELAKKHCGEVMIFE | 111 | Q9P2K8 | |
| EFDHFVVDMKPFVLK | 16 | Q8N8E3 | |
| EMELAKEEKCEFLPF | 376 | Q12882 | |
| PEKCQFFHKERMEVC | 146 | Q06481 | |
| KKMVNVEDVAECPHF | 146 | P35913 | |
| MPIEIVCKIKFAEED | 1 | Q96FT7 | |
| EKHPEKESEACMLVF | 846 | Q9UKK3 | |
| EDVTHKFNKPCIMDV | 131 | Q8NFU5 | |
| FTQHKFVKICMEEPR | 261 | Q9NPH5 | |
| LLEHMKCEIIKEFPE | 676 | Q8NB91 | |
| CMVPEHFEKTIFLIA | 161 | A6NN92 | |
| EHVKPLFNMEDKICL | 256 | Q13867 | |
| EEGEVTVCFKMKHDF | 411 | Q9UJW0 | |
| FKCDSLKEECIPEHM | 216 | Q9Y2M0 | |
| EMCHEEKVDFIKDAV | 311 | A1L4K1 | |
| PCFEEEEHFKVLVKM | 691 | Q5JRX3 | |
| VKEKISMFCHVEPEQ | 226 | P17812 | |
| EKKCFIEEIPDETMV | 46 | Q9BVK6 | |
| VDVFKEKHMAPEFCS | 371 | P24557 | |
| VPELHMFDHFCKKEP | 191 | Q92610 | |
| FDKMPEVITIHLKCF | 521 | O94782 | |
| EAFCEATHIPMEKLK | 1066 | Q5TIE3 |